Advertisement

Abemaciclib + Endocrine Therapy Improves Survival in HR-Positive, HER2-Negative Early Breast Cancer

0

15.8 percent lower risk for death seen with abemaciclib-ET versus ET in intent-to-treat population

Enzalutamide + Leuprolide Boosts Overall Survival for Prostate Cancer With High Recurrence Risk

0

Enzalutamide monotherapy was not superior to leuprolide alone

Sentinel Lymph Node Biopsy Noninferior to Lymphadenectomy in Cervical Cancer

0

Sentinel lymph node biopsy alone noninferior with respect to disease-free survival, linked to fewer complications

Loneliness, Social Isolation Tied to Higher Mortality in Patients With Cancer

0

Findings seen for both cancer-specific and all-cause mortality

Recurrence-Free Survival Longer With Nivolumab Than Ipilimumab in Melanoma

0

Median duration of recurrence-free survival was 61.1 months with nivolumab and 24.2 months with ipilimumab

Niraparib Plus AAP Improves Survival in mCSPC With HRR Gene Alterations

0

Significant improvement in radiographic progression-free survival seen first in BRCA subgroup

New $1.3B Lawsuit Accuses Johnson & Johnson of Hiding Baby Powder Cancer Risk

0

The case marks the first group claim against the company in the United Kingdom

Incidence Rates Increased From 2003 to 2017 for Six Cancer Types in 42 Countries

0

Apart from colorectal cancer, increases in incidence were seen in both younger and older adults

CHEST: SGLT2 Inhibitors May Slow Nodule Growth in Pulmonary Malignancies

0

Patients prescribed SGLT2 inhibitors less likely to exhibit nodule growth and to undergo a surgical intervention

FDA to Fast-Track 9 Experimental Drugs Under New Trump Program

0

The drugs include potential new treatments for vaping addiction, deafness, pancreatic cancer and other serious health conditions